Schedule 13G ownership disclosure
CARDIOME PHARMA CORP
Security class unavailable · CUSIP: 14159U301
Event date: 2016-01-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,955,392
- Percent of class
- 20.0900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-16-002901
- Form type
- SC 13G
- Filer
- Correvio Pharma Corp.
- CIK
- CIK 1036141
- Filed
- Feb 10, 2016
- Reporting period
- Jan 29, 2016
- Description
- Schedule 13G beneficial ownership